Susceptibility to several -lactams and -lactamase production was investigated in a collection of 20 strains of Pseudomonas otitidis, a new Pseudomonas species that has been recently recognized in association with otic infections in humans. All strains appeared to be susceptible to piperacillin, cefotaxime, ceftazidime, and aztreonam, while resistance or decreased susceptibility to carbapenems was occasionally observed. All strains were found to express metallo--lactamase (MBL) activity and to carry a new subclass B3 MBL gene, named bla POM , that appeared to be highly conserved in this species. P. otitidis, therefore, is the first example of a pathogenic Pseudomonas species endowed with a resident MBL. The POM-1 protein from P. otitidis type strain MCC10330 exhibits the closest similarity (60 to 64%) to the L1 MBL of Stenotrophomonas maltophilia. Expression in Escherichia coli and Pseudomonas aeruginosa revealed that, similar to L1 and other subclass B3 MBLs, POM-1 confers decreased susceptibility or resistance to carbapenems, penicillins, and cephalosporins but not to aztreonam. Expression of the POM MBL in P. otitidis is apparently constitutive and, in most strains, does not confer a carbapenem-resistant phenotype. However, a strong inoculum size effect was observed for carbapenem MICs, and carbapenem-resistant mutants could be readily selected upon exposure to imipenem, suggesting that carbapenem-based regimens should be considered with caution for P. otitidis infections.
Pseudomonas otitidis is a newPseudomonas species that has recently been recognized in association with otic infections in humans, including acute otitis externa, acute otitis media, and chronic suppurative otitis media (2). Genotypically and phenotypically, P. otitidis is closely related to Pseudomonas aeruginosa (2), and this similarity likely accounts for the belated identification of this new pathogenic species within the Pseudomonas genus.The susceptibility of P. otitidis was previously investigated with several antimicrobial agents, including aminoglycosides, fluoroquinolones, macrolides, -lactams, tetracycline, chloramphenicol, and polymyxin B, and overall, the behavior of this species appeared to be similar to that of P. aeruginosa (2). However, of -lactams, only piperacillin was tested, while no information is available on the susceptibility of this species to antipseudomonal cephalosporins, aztreonam, and carbapenems.In this work, we investigated the susceptibility of P. otitidis to several -lactams and the production of -lactamase activity by this species. Results revealed that P. otitidis strains constitutively produce a novel subclass B3 metallo--lactamase (MBL), that was named POM (after P. otitidis metallo--lactamase), which is active on carbapenems and other -lactams.
MATERIALS AND METHODSBacterial strains. The P. otitidis strains investigated in this work included 19 strains from the collection previously described by Clark et al. (2) and a clinical isolate from South Korea (isolate YMC-Po/06) cultured from the puru...